C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof

Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2004
11/11/2004	US20040224886 Stabilized compositions comprising tissue factor pathway inhibitor protein or tissue factor pathway inhibitor variant proteins
11/11/2004	US20040224882 modulating cell growth, cell differentiation, or cell survival; genetic engineering using hedgehog genes and proteins; neurodegenerative diseases; tissue-targeted therapy
11/11/2004	US20040224424 Nucleotide sequences comprising allelic variant of cytochrome p450 for use in diagnosis and treatment of cell proliferative, nervous system and cardiovascular disorders; pharmacodynamic profiles and drug screening
11/11/2004	US20040224412 Repressor-mediated regulation system for control of gene expression in plants
11/11/2004	US20040224411 Transgenic cell comprising adenoviral vector for use as gene delivery tool; tissue engineering heterologous gene expression; DNA vaccines
11/11/2004	US20040224409 Replication defective plasmid comprising nucleotide sequences coding nerve growth factor for use in the treatment and/or prevention of degenerative neurological diseases; tissue engineering and targeted therapy
11/11/2004	US20040224408 THAP proteins as nuclear receptors for chemokines and roles in transcriptional regulation, cell proliferation and cell differentiation
11/11/2004	US20040224407 Expression vector for consistent cellular expression of the tet on repressor in multiple cell types
11/11/2004	US20040224400 Novel multifunctional adhesin proteins and their display in microbial cells
11/11/2004	US20040224398 TIMP3 as VEGF inhibitor
11/11/2004	US20040224393 Modified human granulocyte-colony stimulating factor and process for producing same
11/11/2004	US20040224392 Novel human 26649, 3259, 57809, 57798, 33358, and 32529 molecules and uses therefor
11/11/2004	US20040224389 Viral vectors encoding apoptosis-inducing proteins and methods for making and using the same
11/11/2004	US20040224388 Hyphal growth in fungi
11/11/2004	US20040224387 Comprises nucleotide sequences coding fibroblast growth factors for use in prevention and treatment of reproductive, metabolic, kidney, oral, breast, skin and brain disorders; wound healing agents and cosmetic surgery
11/11/2004	US20040224386 Protein tyrosine kinases
11/11/2004	US20040224385 Zinc finger binding domains for cnn
11/11/2004	US20040224370 Fluorescence guided cell capture
11/11/2004	US20040224365 Fluorescent amyloid Abeta peptides and uses thereof
11/11/2004	US20040224357 Nucleotide sequences coding salivary gland microbial polypeptide for use in diagnosis and treatment of digestive, endocrine and immune system disorder
11/11/2004	US20040224350 Dirofilaria non-collagenous protein for use in developing vaccine for prevention and treatment of nematode infection; veterinary medicine
11/11/2004	US20040224338 Profiling and cataloging expressed protein tags
11/11/2004	US20040224335 Methods and compositions for treatment of tumors using nucleic acid ligands to platelet-derived growth factor
11/11/2004	US20040224327 Modified open reading frames comprised of ribonucleic acid sequences from non infectious porcine reproductive respiratory syndrome virus for use in generation of vaccine to prevent viral infection of pigs; veterinay medicine
11/11/2004	US20040224320 Method for efficiently determining a DNA strand break
11/11/2004	US20040224314 G-protein coupled receptors
11/11/2004	US20040224313 Comprises nucleotide sequences coding cytochrome p450 oxygenase variant for identifying modulator use in diagnosis, prognosis, treatment and prevention of cell proliferative disorders; antitumor agents
11/11/2004	US20040224309 Nucleotide sequences coding viral genome for use in developing vaccine to prevent respiratory system infections; genetic vaccines
11/11/2004	US20040224308 Nucleotide sequences coding viral glycoprotein for use in generating modulators for prevention and treatment of viral infection; viricides; immunotherapy
11/11/2004	US20040224305 Chimeric human papillomavirus (HPV) L1 molecules and uses therefor
11/11/2004	US20040223979 Chimeric flavivirus vaccines
11/11/2004	US20040223977 fusion peptide of an HIV CTL epitope and a T helper epitope induces potent epitope-specific CTL responses following a single administration in aqueous solution and can be further boosted with repeated administrations
11/11/2004	US20040223976 Influenza virus vaccine
11/11/2004	US20040223969 modulating tumor growth by contacting a tumor cell with an agonist or antagonist of IL-23, particularly a binding mixture of IL-23R or nucleotide coding it comprising: an antigen-binding site of an antibody; an extracellular region of IL-23R; a small molecule; and an anti-sense nucleic acid or siRNA
11/11/2004	US20040223968 inhibiting a condition characterized by monocytic infiltrates such as atherosclerosis by administering an MCP-1 receptor antagonist that binds to an MCP-1 receptor polypeptide, especially a humanized or monoclonal antibody.
11/11/2004	US20040223966 inhibiting growth and differentiation factor-8 activity; diagnosing, preventing, or treating degenerative disorders of muscle, bone, or glucose homeostasis.
11/11/2004	US20040223965 Hepatitis b core antigen fusion proteins
11/11/2004	US20040223964 Secreted and transmembrane polypeptides and nucleic acids encoding the same
11/11/2004	US20040223952 Generation and/or reduction of new lung tissue in an affected lung
11/11/2004	US20040223950 the bond to the IFN-alpha 2a is at a lysine residue; isolation using liquid chromatography; prophylaxis of viral or immunomodulatory diseases, especially for the treatment of viral diseases
11/11/2004	US20040223323 Optical information carrier comprising immobilized proteorhodopsin
11/11/2004	DE10318087A1 New plant proteins of the pathogen and circadian controlled-1 family, useful for regulating flowering time and for increasing resistance to pathogens
11/11/2004	DE10317369A1 proNGF als pharmazeutisch wirksames Mittel zur Behandlung demyelinisierender Erkrankungen proNGF as pharmaceutically active agents for treating demyelinating diseases
11/11/2004	CA2847490A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
11/11/2004	CA2847486A1 Template-fixed beta-hairpin peptidomimetics with cxcr4 antagonizing activity
11/11/2004	CA2525488A1 Extraction process for a pharmaceutical product
11/11/2004	CA2524360A1 Novel composition and methods for the treatment of immune disorders
11/11/2004	CA2524270A1 Method for the production of an n-terminally modified chemotactic factor
11/11/2004	CA2524071A1 Toll-like receptor 9 effector agents and uses thereof
11/11/2004	CA2523875A1 Sars virus nucleotide and amino acid sequences and uses thereof
11/11/2004	CA2523537A1 Pathophysiology associated with a single gene (mass1) mutation underlying the robust audiogenic seizure phenotype in frings mice
11/11/2004	CA2523508A1 Galectin 9-inducing factors
11/11/2004	CA2523402A1 Group 1 mite polypeptide variants
11/11/2004	CA2523323A1 Genes upregulated in a tomato plant having an increased anthocyanin content phenotype
11/11/2004	CA2523319A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
11/11/2004	CA2523266A1 Compositions comprising cationic microparticles and hcv e1e2 dna and methods of use thereof
11/11/2004	CA2523025A1 Spex compositions and methods of use
11/11/2004	CA2523022A1 Nogo-b, a regulator of endothelial cell function and vessel remodeling
11/11/2004	CA2522895A1 Combined use of keratinocyte growth factor agonists and gastrin compounds
11/11/2004	CA2522460A1 Beta-amyloid inhibitors and use thereof
11/11/2004	CA2522108A1 Secreted protein family
11/11/2004	CA2520243A1 Pharmaceutical compositions for treating painful neuropathy and methods of treating same
11/11/2004	CA2519241A1 Compositions and methods for the diagnosis and treatment of tumor
11/11/2004	CA2519207A1 Adenovirus serotype 34 vectors, nucleic acids and virus produced thereby
11/11/2004	CA2518776A1 Insulin analogs having protracted time action
11/10/2004	EP1475639A2 Tumour-specific P450 protein
11/10/2004	EP1475442A2 Polypeptides of feline T-cell lymphotropic lentivirus
11/10/2004	EP1475441A2 Specific nucleic acids and polypeptide from pathogenic strains of Neisseria
11/10/2004	EP1475440A2 Growth differentiation factor-3
11/10/2004	EP1475438A1 Method for the preparation of antigens derived from filaggrin and their use for diagnosing rheumatoid arthritis
11/10/2004	EP1475436A1 Swine rag-1 gene and utilization thereof
11/10/2004	EP1475389A1 Human secreted protein that shares sequence homology with the murine Sperizin protein
11/10/2004	EP1475388A2 Novel human calcium sensitive potassium channel subunits
11/10/2004	EP1474528A2 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer
11/10/2004	EP1474521A2 An herpes simplex virus complex
11/10/2004	EP1474519A2 Microorganism for genetic therapeutic treatment of proliferative diseases
11/10/2004	EP1474517A2 Mutated gene coding for a lat protein and the biological applications thereof
11/10/2004	EP1474516A2 Methods of modulating cold sensory perception
11/10/2004	EP1474515A2 Regulation of human hematopoietin receptor-like protein
11/10/2004	EP1474510A2 Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
11/10/2004	EP1474451A2 De-immunized (poly)peptide constructs
11/10/2004	EP1474448A1 Rrp sequences and knockout mice and uses thereof
11/10/2004	EP1474447A2 Antigens for immunocontraception
11/10/2004	EP1474446A2 Mhc class ii peptide epitope of 5t4 antigen
11/10/2004	EP1474445A1 Glycoisoforms of adiponectin and uses thereof
11/10/2004	EP1474444A1 A novel splice variant of myd88 and uses thereof
11/10/2004	EP1474443A1 Tolerogenic peptides from myelin basic protein
11/10/2004	EP1474442A2 Cytotoxic t-cell epitopes from chlamydia
11/10/2004	EP1474438A2 Methods for the production of purified recombinant human uteroglobin for the treatment of inflammatory and fibrotic conditions
11/10/2004	EP1474434A2 The eaat2 promoter and uses thereof
11/10/2004	EP1474430A1 Bi-functionalised metallocenes use for marking biological molecules
11/10/2004	EP1474176A2 Novel human g-protein coupled receptor, hgprbmy31, and variants and methods of use thereof
11/10/2004	EP1474175A2 Agents that regulate apoptosis
11/10/2004	EP1474167A2 Novel proteins in enteroaggregative esheriachia coli (eaec) useful for diagnosis and therapy of eaec infections
11/10/2004	EP1474166A2 Ehrlichia disulfide bond formation proteins and uses thereof
11/10/2004	EP1474161A2 Engineered binding proteins
11/10/2004	EP1425045A4 Adenoviral vector and related system and methods of making and use
11/10/2004	EP1265570B1 Soluble keratin peptide
11/10/2004	EP1202629B1 Insect control system
11/10/2004	EP1012280B1 Trimerising module

1 ... 1305 1306 1307 1308 1309 1310 1311 1312 1313 1314 1315 1316 1317 1318 1319 1320 1321 1322 1323 1324 1325 ... 2916